
1. malar j. 2011 jan 28;10:18. doi: 10.1186/1475-2875-10-18.

prevalence resistance associated polymorphisms plasmodium falciparum field 
isolates southern pakistan.

ghanchi nk(1), ursing j, beg ma, veiga mi, jafri s, mårtensson a.

author information: 
(1)malaria research lab, infectious diseases unit, department medicine,
karolinska university hospital/karolinska institutet, retziusväg 10, stockholm,
sweden.

background: scarce data available plasmodium falciparum anti-malarial drug
resistance pakistan. aim study was, therefore, determine the
prevalence p. falciparum resistance associated polymorphisms field isolates
from southern pakistan.
methods: blood samples 244 patients blood-slide confirmed p. falciparum
mono-infections collected 2005-2007. single nucleotide polymorphisms
in p. falciparum chloroquine resistance transporter (pfcrt k76t), multi drug 
resistance (pfmdr1 n86y), dihydrofolate reductase (pfdhfr a16v, n51i, c59r,
s108n, i164l) dihydropteroate synthetase (pfdhps a436s, g437a e540k)
genes pfmdr1 gene copy numbers determined using pcr based methods.
results: prevalence pfcrt 76t pfmdr1 86y 93% 57%,
respectively. prevalence pfdhfr double mutations 59r + 108n/51r + 108n was
92%. pfdhfr triple mutation (51i, 59r, 108n) occurred 3% samples. the
pfdhfr (51i, 59r, 108n) pfdhps (437g, 540e) quintuple mutation found in
one isolate. pfdhps 437g observed 51% 540e 1% isolates. one 
isolate two pfmdr1 copies carried pfmdr1 86y pfcrt 76t alleles.
conclusions: results indicate high prevalence vivo resistance to
chloroquine, whereas high grade resistance sulphadoxine-pyrimethamine not
appear widespread among p. falciparum southern pakistan.

doi: 10.1186/1475-2875-10-18 
pmcid: pmc3037930
pmid: 21272384  [indexed medline]

